Cannabis Groups Renew Call for Removing DEA from Rescheduling Process – Ganjapreneur | Where to buy Skittles Moonrock online
Learn where to order weed online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
š Click here to Visit our shop! š

Wed / Jan 8th
Cannabis reform proponents have again requested the removal of the Drug Enforcement Administration (DEA) from the rescheduling hearing coming later this month, citing new evidence the agency might seek to āsubvert the processā and āthwartā the rescheduling process.
Full story after the jump.
Cannabis advocacy group Hemp for Victory and Village Farms International, Inc. has again requested the removal of the Drug Enforcement Administration (DEA) from the federal cannabis rescheduling hearing coming later this month. The request, which was first filed and subsequently dismissed last year, claims the agencyās opposition to the proposed rescheduling of cannabis from Schedule I to Schedule III jeopardizes its role overseeing the hearing.
The new complaint asks the judge overseeing the hearing to reconsider the groupsā initial motion in light of new evidence which, according to the request, reveals āundisclosed conflicts of interest and extensive improper ex parte communications by the DEA.ā
The groupsā attorney, Shane Pennington of Porter Wright Morris & Arthur, said the evidence āstrongly suggests the DEA is using its authority in these proceedings to subvert the process and thwart the Schedule III proposal which it vehemently opposes.ā
Village Farmsā CEO and founder Michael DeGiglio said in a statement that the groupsā initial complaint had āreflected a desire for a more transparent process consistent with the rule of law and precedent proceedings.ā
āHowever, since then our view has only strengthened that these proceedings are a sham orchestrated by the DEA to stonewall cannabis from being transferred to a Schedule III designation. This would be a disgraceful outcome that will continue to harm the health and safety of Americans and benefit Big Pharma and harmful addictive drugs like opioids. On behalf of our entire industry, we intend to do everything we can to support the rescheduling of cannabis and to prevent a failed outcome from occurring.ā ā DeGiglio, in a press release
Witness testimony in the hearing is set to begin on January 21 and continue every Tuesday, Wednesday, and Thursday until March 3.
Get daily cannabis business news updates. Subscribe
Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.
Ganjapreneur is made possible by our partners:
Latest Cannabis News
Wisconsin Gov. Wants to Allow Citizen-Led Ballot Initiatives for Issues Like Cannabis Reforms
Hawaii Gov. Signs Executive Order to Protect Caregivers as Some Medical Cannabis Provisions Expire
Bills Filed in Oklahoma Contain New Medical Cannabis Purchase Limits, Advertising Restrictions
Agrify Corp. Sells Cultivation Business and Shifts Focus to Cannabis Beverages
Texas AG Commissioner Calls for Restricting Hemp Products & Expanding Medical Cannabis
Top Cannabis Regulator In Delaware Resigns After Retail Licenses Awarded
News by Market:
News by Topic:
- Stocks
- CBD
- Legalization
- Decriminalization
- Business
- Regulations
- Adult Use
- Medical Cannabis
- Social Equity
- Expungement
- Veterans
- Hemp Industry
- Events
- Politics
- Federal Policy
- Law Enforcement
- International
- Entrepreneurs
- Investing
- Licensing
- Banking
- Marketing
- Technology
- Celebrities
- Sports
- Popular Culture
- Normalization
- Extracts
- Edibles
- Lawsuits
Featured Business Profiles
From Our Partners
Top Shelf DNA Genetics Strains for Indoor Growing Success
DNA Genetics
The 2024 Election and Cannabis Legalization: A Critical Turning Point
BGM CPA
Seeds of Success: Unveiling DNA Geneticsā Best Cannabis Strains
DNA Genetics


Leave a Reply
Want to join the discussion?Feel free to contribute!